ArticleFrontiers in immunology2024

The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.

Amandine Decroos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.